Avastin No Help in Advanced NSCLC – MedPage Today

by lowes1 on April 18, 2012


Health Newstrack
Avastin No Help in Advanced NSCLC
MedPage Today
This study found that adding bevacizumab (Avastin) to chemotherapy doesn't prolong life for seniors more than 65 with advanced non-small cell lung cancer (NSCLC). Note that none of the propensity-adjusted models controlling for demographic and clinical
Bevacizumab Not Effective in Advanced Lung Cancer in the ElderlyMedscape
Adding Drug to Standard Chemotherapy Provides No Survival Benefit for Older Newswise (press release)
Study examines drug regimen for the treatment of non-small cell lung cancer Science Codex
The Oncology Report -PLoS Blogs (blog) -Medical News Today
all 21 news articles »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: